Talks Underway To End Cocrystal Pharma Stock-Drop Suit
Settlement talks are underway in a derivative suit brought by Cocrystal Pharma Inc. shareholders over a $27 million pump-and-dump scheme that purportedly drove down the value of the company's stock, according...To view the full article, register now.
Already a subscriber? Click here to view full article